Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | IDH1 | O75874 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | PGK2 | P07205 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | IGF1R | P08069 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28266224 | 0.93 | TNKS2 (0.41) | TNKS2HPGDNPC1MAPK1HTT | |
| SCHEMBL29530874 | 0.89 | CA2 (0.43) | TNKS2HPGDNPC1MAPK1HTT | |
| SCHEMBL16953115 | 0.85 | TNKS2 (0.41) | TNKS2HPGDNPC1MAPK1HTT | |
| SCHEMBL17365381 | 0.85 | TNKS2 (0.41) | TNKS2HPGDNPC1MAPK1HTT | |
| SCHEMBL16959217 | 0.85 | TNKS2 (0.41) | TNKS2HPGDNPC1MAPK1HTT | |
| SCHEMBL7429249 | 0.84 | TDP1 (0.42) | HPGDCYP4A11CYP4F2IDH1ALDH1A1 | |
| SCHEMBL8086536 | 0.84 | PTGS2 (0.42) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL8086639 | 0.84 | NPC1 (0.41) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL8086884 | 0.81 | PTGS2 (0.44) | HPGDNPC1MAPK1HTTRAB9A | |
| SCHEMBL8098721 | 0.81 | PTGS2 (0.44) | HPGDNPC1MAPK1HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103874675-A | Process for the preparation of methoxymelonal | GIVAUDAN SA | 2014-06-18 | — | — | CN | claimed |
| CN-100356901-C | Body odor mimetic composition and perfume composition for suppressing body odor | TAKASAGO PERFUMERY CO LTD (JP) | 2007-12-26 | — | — | CN | claimed |
| CN-109310620-A | A kind of Haircare composition | 西姆莱斯股份公司 | 2019-02-05 | — | — | CN | disclosed |
| EP-2168944-B1 | AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-11 | — | — | EP | disclosed |
| EP-2168944-B1 | AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-11 | — | — | EP | disclosed |
| US-9321045-B2 | Catalyst and process for synthesising the same | THE UNIVERSITY OF WARWICK (GB) | 2016-04-26 | — | — | US | disclosed |
| CN-103874675-B | The preparation method of methoxyl group melonal | GIVAUDAN S.A. (CH) | 2015-11-25 | — | — | CN | disclosed |
| US-20150290634-A1 | Catalyst and Process for Synthesising the Same | THE UNIVERSITY OF WARWICK (GB) | 2015-10-15 | — | — | US | disclosed |
| CN-101730677-B | Amine compound and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORP | 2014-07-16 | — | — | CN | disclosed |
| CN-103874675-A | Process for the preparation of methoxymelonal | GIVAUDAN SA | 2014-06-18 | — | — | CN | disclosed |
| US-8129361-B2 | Amine compound and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| CN-1385457-A | Gel composition | PANRICO PARTNERSHIP INC (US) | 2002-12-18 | — | — | CN | disclosed |
| CN-1087936-C | Antipsychotic method | NOVO NORDISK AS (DK) | 2002-07-24 | — | — | CN | disclosed |
| CN-1324380-A | Gel composition | PENRECO (US) | 2001-11-28 | — | — | CN | disclosed |
| EP-0634449-B1 | Polyether with sterically hindered amine side chains as stabilizing agents | CIBA GEIGY AG (CH) | 1999-09-01 | — | — | EP | disclosed |
| US-5719257-A | OBTAINED BY ANIONIC POLYMERIZATION OF DERIVATIVES OF 2,2,6,6-TETRAMETHYL-4-/2,3-EPOXYPROPOXY/PIPERIDINE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| US-5616637-A | PHOTOSTABILITY; OXIDTION AND HEAT RESISTANT | CIBA-GEIGY CORPORATION (US) | 1997-04-01 | — | — | US | disclosed |
| CN-1133008-A | Antipsychotic method | NOVO NORDISK AS (DK) | 1996-10-09 | — | — | CN | disclosed |
| US-5521282-A | FROM 4-/2,3-EPOXYPROPOXY/-2,2,6,6-TETRAMETHYLPIPERIDINE | CIBA-GEIGY CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0634449-A2 | Polyether with sterically hindered amine side chains as stabilizing agents | CIBA-GEIGY AG (CH) | 1995-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150290634-A1 | Catalyst and Process for Synthesising the Same | CBR3, SPR, RNF5 | TNKS2 161/4885HPGD 1633/4885NPC1 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.